Alpha-solanine inhibits endothelial inflammation via nuclear factor kappa B signaling pathway
Advances in Clinical and Experimental Medicine · 2023
DOI: 10.17219/acem/158781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Nan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Zhejiang Chinese Medical University Affiliated Jiangnan Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: NF-kappa B, I-kappa B Kinase. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Zhejiang Chinese Medical University Affiliated Jiangnan Hospital, Hangzhou, China.
- Outpatient Department of Surgery, Zhejiang Chinese Medical University Affiliated Jiangnan Hospital, Hangzhou, China.
- Department of Nursing, Zhejiang Chinese Medical University Affiliated Jiangnan Hospital, Hangzhou, China.
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China.
Zitieren
APA
Wang, N., Jiang, D., Zhou, C., & Han, X. (2023). Alpha-solanine inhibits endothelial inflammation via nuclear factor kappa B signaling pathway. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/158781
Vancouver
Wang N, Jiang D, Zhou C, Han X. Alpha-solanine inhibits endothelial inflammation via nuclear factor kappa B signaling pathway. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/158781
BibTeX
@article{Wang2023,
author = {Wang, Nan and Jiang, Daquan and Zhou, Chunxiu and Han, Xi},
title = {Alpha-solanine inhibits endothelial inflammation via nuclear factor kappa B signaling pathway},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
doi = {10.17219/acem/158781}
}
EUVIMED